254 related articles for article (PubMed ID: 26012148)
1. [Resistant hypertension and reasons for excluding patients from treatment with renal denervation].
Prkačin I; Cavrić G; Počanić D; Leder N; Vidjak V
Acta Med Croatica; 2014 Apr; 68(2):117-20. PubMed ID: 26012148
[TBL] [Abstract][Full Text] [Related]
2. International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertension.
Schlaich MP; Schmieder RE; Bakris G; Blankestijn PJ; Böhm M; Campese VM; Francis DP; Grassi G; Hering D; Katholi R; Kjeldsen S; Krum H; Mahfoud F; Mancia G; Messerli FH; Narkiewicz K; Parati G; Rocha-Singh KJ; Ruilope LM; Rump LC; Sica DA; Sobotka PA; Tsioufis C; Vonend O; Weber MA; Williams B; Zeller T; Esler MD
J Am Coll Cardiol; 2013 Dec; 62(22):2031-45. PubMed ID: 24021387
[TBL] [Abstract][Full Text] [Related]
3. Renal denervation and hypertension resistant drug treatment in patient with renal artery accessory.
Imbalzano E; Ceravolo R; Vatrano M; Lizio G; Saitta A
Int J Cardiol; 2014 Jan; 171(1):e8-9. PubMed ID: 24331865
[No Abstract] [Full Text] [Related]
4. "In-stent" renal denervation for the treatment of severe resistant hypertension.
Marchese A; Secco GG; Chierchia S; Iorio E; Castriota F
Int J Cardiol; 2014 May; 173(3):e25-6. PubMed ID: 24713456
[No Abstract] [Full Text] [Related]
5. Distal and Tributary Targets: A New Branching Point for Renal Denervation?
Sawlani NN; Bhatt DL
J Am Coll Cardiol; 2015 Oct; 66(16):1776-1778. PubMed ID: 26483100
[No Abstract] [Full Text] [Related]
6. Endovascular renal artery denervation: why, when, and how?
Sapoval M; Azizi M; Bobrie G; Cholley B; Pagny JY; Plouin PF
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):463-71. PubMed ID: 22314774
[TBL] [Abstract][Full Text] [Related]
7. The future for renal denervation depends on embracing the lessons learned from our previous studies.
Epstein M
J Am Soc Hypertens; 2016 May; 10(5):396-8. PubMed ID: 27079956
[TBL] [Abstract][Full Text] [Related]
8. ESH position paper: renal denervation - an interventional therapy of resistant hypertension.
Schmieder RE; Redon J; Grassi G; Kjeldsen SE; Mancia G; Narkiewicz K; Parati G; Ruilope L; van de Borne P; Tsioufis C
J Hypertens; 2012 May; 30(5):837-41. PubMed ID: 22469838
[TBL] [Abstract][Full Text] [Related]
9. [Percutaneous renal denervation as a new method of treatment of resistant arterial hypertension].
Mach-Jamińska A; Sułowicz W
Przegl Lek; 2012; 69(11):1215-9. PubMed ID: 23646450
[TBL] [Abstract][Full Text] [Related]
10. Catheter-based renal sympathetic denervation: limitations to and gaps in the evidence.
Hiremath S; Froeschl M; Ruzicka M
Curr Opin Cardiol; 2014 Jul; 29(4):336-43. PubMed ID: 24859619
[TBL] [Abstract][Full Text] [Related]
11. Catheter-based renal denervation for resistant hypertension: 12-month results of the EnligHTN I first-in-human study using a multielectrode ablation system.
Papademetriou V; Tsioufis CP; Sinhal A; Chew DP; Meredith IT; Malaiapan Y; Worthley MI; Worthley SG
Hypertension; 2014 Sep; 64(3):565-72. PubMed ID: 24935940
[TBL] [Abstract][Full Text] [Related]
12. Limited destruction of renal nerves after catheter-based renal denervation: results of a human case study.
Vink EE; Goldschmeding R; Vink A; Weggemans C; Bleijs RL; Blankestijn PJ
Nephrol Dial Transplant; 2014 Aug; 29(8):1608-10. PubMed ID: 24875664
[TBL] [Abstract][Full Text] [Related]
13. [Renal denervation a treatment for resistant hypertension: a French experience].
Benamer H; Mylotte D; Garcia-Alonso C; Unterseeh T; Garot P; Louvard Y; Lefevre T; Morice MC;
Ann Cardiol Angeiol (Paris); 2013 Dec; 62(6):384-91. PubMed ID: 24182849
[TBL] [Abstract][Full Text] [Related]
14. [Renal denervation a new treatment option in resistant arterial hypertension].
Himmel F; Bode F; Schunkert H; Weil J
Praxis (Bern 1994); 2011 Nov; 100(22):1353-60. PubMed ID: 22048911
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous renal denervation and the second generation EnligHTN System.
Chokka RG; Delacroix S; Psaltis PJ; Anavekar NS; Worthley SG
Minerva Cardioangiol; 2014 Feb; 62(1):99-104. PubMed ID: 24500220
[TBL] [Abstract][Full Text] [Related]
16. Renal sympathetic denervation for resistant hypertension in a patient with a single kidney.
Xu B; Whitbourn RJ
Med J Aust; 2014 Mar; 200(4):206-7. PubMed ID: 24580520
[No Abstract] [Full Text] [Related]
17. [Catheter-based treatment of drug-resistant hypertension].
De Benedetti E
Rev Med Suisse; 2011 Nov; 7(317):2242-4. PubMed ID: 22400353
[TBL] [Abstract][Full Text] [Related]
18. Comment on ESH position paper: renal denervation--an interventional therapy of resistant hypertension.
Sánchez-Chaparro MA; Valdivielso P; González-Sántos P
J Hypertens; 2012 Dec; 30(12):2441-2; author reply 2443. PubMed ID: 23151886
[No Abstract] [Full Text] [Related]
19. Renal sympathetic denervation for hypertension.
Med Lett Drugs Ther; 2012 Jul; 54(1394):55-6. PubMed ID: 22777305
[No Abstract] [Full Text] [Related]
20. [Endovascular renal nerve ablation as a treatment for resistant hypertension].
Monge M; Lorthioir A; Bobrie G; Briet M; Plouin PF; Sapoval M; Azizi M
J Mal Vasc; 2013 Dec; 38(6):367-72. PubMed ID: 24135305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
